XML 44 R31.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Financial Statement Details (Tables)
12 Months Ended
Dec. 31, 2024
Inventory Disclosure [Abstract]  
Schedule of Inventory

Inventory

Inventory consists of the following (in thousands):

 

December 31,

 

 

2024

 

 

2023

 

Raw materials

 

$

 

 

$

1,861

 

Work-in-process

 

 

 

 

 

12,880

 

Finished goods

 

 

 

 

 

1,360

 

Total inventory

 

$

 

 

$

16,101

 

Schedule of Other Current Assets

Other Current Assets

Other current assets consists of the following (in thousands):

 

 

December 31,

 

 

 

2024

 

 

2023

 

Prepaid research and development expenses

 

$

1,947

 

 

$

4,325

 

Interest and other non-trade receivables

 

 

1,609

 

 

 

1,047

 

Other prepaid expenses

 

 

2,510

 

 

 

4,407

 

Total other current assets

 

$

6,066

 

 

$

9,779

 

Schedule of Property, Plant and Equipment

Property, Plant and Equipment

Property, plant and equipment consists of the following (in thousands):

 

December 31,

 

 

2024

 

 

2023

 

Building and leasehold improvements

 

$

3,881

 

 

$

43,184

 

Laboratory equipment

 

 

552

 

 

 

14,537

 

Computer equipment and software

 

 

14,616

 

 

 

22,438

 

Manufacturing equipment

 

 

 

 

 

24,315

 

Furniture, fixtures, and other

 

 

27

 

 

 

541

 

Depreciable property, plant and equipment at cost

 

 

19,076

 

 

 

105,015

 

Less: accumulated depreciation

 

 

(15,910

)

 

 

(86,898

)

Depreciable property, plant and equipment, net

 

 

3,166

 

 

 

18,117

 

Construction-in-progress

 

 

245

 

 

 

739

 

Property, plant and equipment, net

 

$

3,411

 

 

$

18,856

 

We determined the loss as follows (in thousands):

 

 

Year Ended December 31,

 

 

 

2024

 

2023

 

Proceeds from sales

 

$

 

$

1,245

 

Net book value of assets

 

 

 

 

2,545

 

Total loss on sale of other property, plant and equipment, net

 

$

 

$

1,300

 

 

Schedule of Goodwill

Goodwill

The following is a reconciliation of the change in our goodwill for the year ended December 31, 2023 (in thousands):

 

 

Year Ended
December 31, 2023

 

Goodwill – beginning balance

 

$

76,501

 

Impairment of goodwill

 

 

(76,501

)

Goodwill – ending balance

 

$

 

Schedule of Accred Expenses

Accrued Expenses

Accrued expenses consist of the following (in thousands):

 

 

December 31,

 

 

 

2024

 

 

2023

 

Accrued compensation

 

$

2,832

 

 

$

5,553

 

Accrued research and development expenses

 

 

14,453

 

 

 

10,118

 

Accrued contract termination costs

 

 

2,767

 

 

 

3,020

 

Other accrued expenses

 

 

9,920

 

 

 

3,471

 

Total accrued expenses

 

$

29,972

 

 

$

22,162

 

Schedule of Accumulated Other Comprehensive Income (Loss)

Accumulated Other Comprehensive Income (Loss)

The following table summarizes the changes in accumulated other comprehensive income (loss) by component (in thousands):

 

 

Foreign currency translation

 

 

Available-for-sale securities

 

 

Accumulated Other Comprehensive Income (Loss)

 

Balance at December 31, 2022

 

$

(5,131

)

 

$

(1,776

)

 

$

(6,907

)

Foreign currency translation gain (loss)

 

 

62

 

 

 

 

 

 

62

 

Unrealized gain on available-for-sale securities

 

 

 

 

 

1,826

 

 

 

1,826

 

Reclassification adjustments to income

 

 

5,099

 

 

 

 

 

 

5,099

 

Balance at December 31, 2023

 

 

30

 

 

 

50

 

 

 

80

 

Foreign currency translation gain (loss)

 

 

(4

)

 

 

 

 

 

(4

)

Unrealized gain on available-for-sale securities

 

 

 

 

 

(15

)

 

 

(15

)

Balance at December 31, 2024

 

$

26

 

 

$

35

 

 

$

61

 

The reclassification from accumulated other comprehensive loss relates to the closure of the operations of our foreign subsidiaries and has been included within other income (expense), net in our Consolidated Statement of Operations for the year ended December 31, 2023.